Home    Back

Fluorescite    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
215Tetralogy of Fallot1

215. Tetralogy of Fallot    [ 19 clinical trials,   35 drugs,   (DrugBank: 16 drugs),   16 drug target genes,   47 drug target pathways]
Searched query = "Tetralogy of Fallot", "Fallot tetralogy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 19 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04017975
(ClinicalTrials.gov)		December 20, 201910/7/2019Optical Tissue Identification for Myocardial ArchitectureOptical Tissue Identification for Myocardial Architecture (OPTIMA Study)Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary StenosisDrug: Fluorescite;Device: Cellvizio 100 Series System with Confocal MiniprobesAditya KazaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingN/A18 YearsAll70Phase 2United States